Experienced CEO and President with a proven track record in building and leading biotech companies. Successfully guided a company from inception to IPO and acquisition by Roche for $1.7B. Skilled in Executive Management, Operations, Finance, Business Development, and more. Strong background in biology with degrees from Stanford University. Extensive experience in oncology precision medicine and st...